Why did Laurus Labs buy a stake in a startup ImmunoACT?

Laurus Labs bought a significant minority stake (26.62%) in a cell and gene therapy startup Immuno ACT Biologics is a high gestation and high investment area within the Pharma industry Typical development times range in many years and take about 5+ years on average to really scale up and transition to commercial production This also…More